Market brief — October 12, 2026

Friday’s session closed with the CAC 40 at 7,803.33, up 0.95%; the DAX at 25,087.27, up 1.13%; the Euro Stoxx 50 at 6,173.37, up 0.76%; the S&P 500 at 7,811.54, up 0.59%; and the Nasdaq at 27,366.17, up 0.64%. These are Friday, October 9 closes—not Monday prices. The rally was primarily a geopolitical relief trade and positioning unwind after hopes of US-Iran talks temporarily eased supply fears. That relief is being challenged overnight: tanker incidents and renewed Houthi attacks have pushed Brent to about $105.48 and WTI to $92.44 on Monday, according to market reports published October 12.^[1][2] The dominant regime is therefore still stagflationary: equities have retained momentum, but the oil shock is rebuilding inflation and duration risk.

The key cross-asset divergence is a risk-on equity close confronting renewed energy stress. Friday’s rebound likely reflected short covering and systematic buying rather than a fully validated macro re-rating; oil’s return above $100 makes that positioning vulnerable. Shipping through Hormuz has materially weakened: Kpler data cited by CNN showed only seven tanker transits on one recent day, below half the seven-day average, while attacks on shipping have increased.^[1] The market implication is asymmetric: a credible reopening agreement could trigger another sharp oil reversal and extend equities higher, but any further disruption would raise breakeven-inflation expectations, pressure long-duration technology and steepen the risk premium in credit.

The Cash Scanner confirms momentum leadership rather than a broad cyclical rotation. US technology represents five of the ten strongest signals: Palantir Technologies (PLTR) scores 40 with a 5.2% gap and a 20-day breakout supported by rising volume, while Nutanix (NTNX) scores 34, up 2.1% on a similar breakout and ADX 36. Microsoft (MSFT) scores 34, up 2.4%, with rising vortex, volume, ADX 40 and KST, and Okta (OKTA) scores 33 after a 5.4% gap with ADX 44. Healthcare momentum is also visible in Teva Pharmaceutical Industries (TEVA), score 36 and gap 4.7%, but the concentration remains overwhelmingly US growth and idiosyncratic momentum. That supports continued discretionary and systematic buying, yet does not confirm a durable rotation away from energy and inflation hedges.

Over the next one to five sessions, markets are most likely to trade the credibility—not merely the existence—of US-Iran negotiations and the probability of restoring reliable Hormuz flows. Consensus appears to expect some eventual de-escalation, which is already embedded in Friday’s equity rebound and the prior oil pullback. What remains underpriced is the operational risk: alternative export routes may preserve aggregate volumes but cannot instantly restore normal shipping capacity. A contrarian bullish scenario is that a verified reopening rapidly compresses the geopolitical premium, sending oil sharply lower and allowing technology leadership to broaden; the bearish alternative is that equities fall even as energy shares outperform because inflation expectations overwhelm the relief trade.

The highest-impact catalyst is fresh evidence on negotiations or maritime security. A confirmed reopening would lower oil, volatility and near-term rate fears; another tanker attack or blockade signal would reverse Friday’s positioning. Monday’s scheduled Federal Reserve communication, including a speech by Fed President Susan Collins listed on the week-ahead calendar, matters because any resistance to easing expectations would amplify the duration shock.^[3] US Gulf production disruptions linked to Hurricane Isaias also warrant attention: reports indicated more than 70% of US offshore crude production had been shut, adding a second supply channel to the geopolitical premium.^[2]

Three risks can break current positioning. First, a failed diplomatic channel could lift Brent decisively further above $105 and force renewed inflation repricing. Second, a Treasury-yield rebound would expose the valuation sensitivity of Nasdaq momentum names despite strong technical signals. Third, liquidity could deteriorate if energy volatility and geopolitical headlines trigger systematic de-risking, converting Friday’s short covering into outright selling.

Actionable read: treat Brent near $105 and WTI near $92 as the first confirmation zone; sustained strength with worsening shipping data argues against chasing Palantir Technologies, Nutanix or Okta, while a rapid oil reversal would validate continued exposure to the technology momentum complex. Monitor the S&P 500 at 7,811.54 and the Nasdaq at 27,366.17 as Friday reference closes: a gap higher that holds while oil retreats would confirm discretionary follow-through; an equity fade alongside higher crude would invalidate the relief-trade thesis. Finally, use Microsoft and Palantir Technologies as breadth tests: continued volume-backed strength would signal that systematic growth buying survives the oil shock, whereas leadership narrowing into energy and defensive healthcare would indicate regime reversal.

Bonne journée aux p&l makers.